Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Griffiths

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
Trials|April 5, 2018
SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trialSimon Crabb, Sarah J Danson, James W F Catto, et al.
Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.
Trials|November 11, 2018
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trialSean H Lim, Kim M Linton, Graham P Collins, et al.
Trials|July 10, 2023
A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2)Simon Crabb, Alannah Morgan, Myra S Hunter, et al.
ACS Nano|August 8, 2018
Enhanced Permeability and Retention-like Extravasation of Nanoparticles from the Vasculature into Tuberculosis Granulomas in Zebrafish and Mouse ModelsFederico Fenaroli, Urska Repnik, Yitian Xu, et al.
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2023
Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse modelsNils-Jørgen K Dal, Gabriela Schäfer, Andrew M Thompson, et al.
Eclinicalmedicine|June 16, 2022
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trialDean A Fennell, Catharine Porter, Jason Lester, et al.
BMC Medical Research Methodology|May 14, 2020
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guideMatthew Ventresca, Holger J Schünemann, Fergus Macbeth, et al.
Health Technology Assessment (Winchester, England)|September 13, 2024
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCTMiriam Santer, Megan Lawrence, Sarah Pyne, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
Trials|April 5, 2018
SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trialSimon Crabb, Sarah J Danson, James W F Catto, et al.
Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.
Trials|November 11, 2018
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trialSean H Lim, Kim M Linton, Graham P Collins, et al.
Trials|July 10, 2023
A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2)Simon Crabb, Alannah Morgan, Myra S Hunter, et al.
ACS Nano|August 8, 2018
Enhanced Permeability and Retention-like Extravasation of Nanoparticles from the Vasculature into Tuberculosis Granulomas in Zebrafish and Mouse ModelsFederico Fenaroli, Urska Repnik, Yitian Xu, et al.
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2023
Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse modelsNils-Jørgen K Dal, Gabriela Schäfer, Andrew M Thompson, et al.
Eclinicalmedicine|June 16, 2022
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trialDean A Fennell, Catharine Porter, Jason Lester, et al.
BMC Medical Research Methodology|May 14, 2020
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guideMatthew Ventresca, Holger J Schünemann, Fergus Macbeth, et al.
Health Technology Assessment (Winchester, England)|September 13, 2024
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCTMiriam Santer, Megan Lawrence, Sarah Pyne, et al.
Pageof 25